Physiology and gene expression characteristics of carcinogen-initiated and tumor-transformed glial progenitor cells derived from the CNS of methylnitrosourea (MNU)-treated Sprague-Dawley rats

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 11, 2004, Pages 1182-1199

  Kokkinakis, Demetrius M ^a,d   Rushing, Elisabeth J ^b   Shareef, Mohammed M ^c   Ahmed, Mansoor M ^c   Yang, Shuting ^a   Singha, Ujjal K ^a   Luo, Jianhua ^d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Animal models; Central nervous system (CNS) tumors; Glial progenitors; Methylnitrosourea

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 4; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; METHYLNITROSOUREA; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; RUBIDIUM; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL STRUCTURE; COMPARATIVE ANATOMY; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; GENE EXPRESSION; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; STEM CELL; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING;

EID: 8544272517     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.11.1182     Document Type: Article

References (59)

1. th ed., Philadelphia, PA: Lippincott Co, 1997:2013-22
2. Ichimura K, Schmidt EE, Goike HM, Collins VP. Human glioblastomas with no alterations of the CDKN2 (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 199;13:1065-72
3. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A 1987;84:6899-903
4. Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992;52:3213-19
5. Yamaguchi F, Saya H, Bruner JM, Morrison R. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci U S A 1994;91:484-88
6. Trojan T, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci U S A 1992;89:4874-78
7. Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995;81:727-36
8. Moriya S, Kazlauskas A, Akimoto K, et al. Platelet-derived growth factor activates protein kinase C through redundant and independent signaling pathways involving phospholipase C or phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1996;93:151-55
9. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific chromosomal losses predict chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90: 1473-79
10. Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis. Clin Cancer Res 2001;7:839-45
11. Kokkinakis DM, Watson ML, Honig LS, Rushing EJ, Mickey BE, Schold SC. Characterization of initiated cells in N-Methylnitrosourea induced carcinogenesis of the central nervous system in the adult rat. Neuro-Oncol 2001;3:99-112
12. Gensert JM, Goldman JE. In vivo characterization of endogenous proliferating cells in adult rat subcortical white matter. Glia 1996; 17:39-51
13. Nishiyama A, Lin X-H, Giese N, Heldin C-H, Stallcup WB. Colocalization of NG2 proteoglycan and PDGF -receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 1996;43: 299-314
14. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble M. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 1988;333:562-65
15. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 1988;53:309-19
16. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988;333:560-62
17. Calver AR, Hall AC, Yu W-P, et al. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 1988;20:869-82
18. Bögler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of O-2A progenitor cells. Proc Natl Acad Sci U S A 1990;87:6368-72
19. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993;118:283-95
20. Bansal R, Kumar M, Murray K, Morrison RS, Pfeiffer SE. Regulation of FGF receptors in the oligodendrocyte lineage. Mol and Cell Neurosci 1996;7:263-75
21. Baron-Van Evercooren A, Olichon-Berthe C, Kowalski A, Visciano G, Van-Obberghen E. Expression of IGF-I and insulin receptor genes in the rat central nervous system: A developmental, regional, and cellular analysis. J Neurosci Res 1991;28:244-53
22. Ballotti R, Nielsen FC, Pringle N, Kowalski A, Richardson WD, Van Obberghen E, Gammeltoft S. Insulin-like growth factor I in cultured rat astrocytes: Expression of the gene and receptor tyrosine kinase. EMBO J 1987;6:3633-39
23. McMorris FA, Smith TM, DeSalvo S, Furlanetto RW. Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development. Proc Natl Acad Sci U S A 1986;83:822-26
24. Shemer J, Raizada MK, Masters BA, Ota A, LeRoith D. Insulin-like growth factor I receptors in neuronal and glial cells. Characterization and biological effects in primary culture. J Biol Chem 1987;262:7693-99
25. Morford LA, Boghaert ER, Brooks WH, Roszman TL. Insulin-like growth factors (IGF) enhance three-dimensional (3D) growth of human glioblastomas. Cancer Lett 1997;115:81-90
26. Shimasaki S, Gao L, Shimonaka M, Ling N. Isolation and molecular cloning of insulin-like growth factor-binding protein-6. Mol Endocrinol 1991;5:938-48
27. Hwa V, Oh Y, Rosenfeld RG. Insulin-like growth factor binding proteins: A proposed superfamily. Acta Peadiatr Suppl 1999;88:37-45
28. Clemmons DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997; 8:45-62
29. Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 1996;25:591-614
30. Kelley KM, Oh Y, Gargosky SE, et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996;28:619-37
31. Sandberg AC, Engberg C, Lake M, Von Holst H, Sara VR. The expression of insulin-like growth factor I and insulin-like growth factor ii genes in the human fetal and adult brain and in glioma. Neurosci Lett 1988;93:114-19
32. Nordqvist AC, Peyrard M, Pettersson H, et al. A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas. Cancer Res 1997;57:2611-14
33. Zumkeller W, Muller D, Muller S, Gunther C, Westphal M. Expression and synthesis of insulin-like growth factor-binding proteins in human glioma cell lines. Int J Oncol 1998;12:129-35
34. Nakayama M, Nakajima D, Nagase T, Nomura N, Seki N, Ohara O. Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening. Genomics 1988;51:27-34
35. Matrisian LM, Glaichenhaus N, Gesnel MC, Breathnach R. Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J 1985;4:1435-40
36. TIS21/PC3 induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 2002;21:6772-78
37. Corrente G, Guardavaccaro D, Tirone F. PC3 Potentiates NGF-induced differentiation and protects neurons from apoptosis. NeuroReport 2002;13:417-22
38. Bradbury A, Possenti R, Shooter EM, Tirone F. Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci U S A 1991;88:3353-57
39. Montagnoli A, Guardavaccaro D, Starace G, Tirone F. Overexpression of the nerve growth factor-inducible PC3 immediate early gene is associated with growth inhibition. Cell Growth Differ 1996;7: 1327-36
40. Robinson S, Cohen M, Prayson R, Ransohoff RM, Tabrizi N, Miller RLH. Constitutive expression of growth-related oncogenes and its receptor in oligodendrogliomas. Neurosurgery 2001;48:864-73
41. Shoshan Y, Nishiyama A, Chang A, et al. Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors. Proc Natl Acad Sci USA 1999;96: 10361-66
42. Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, James CD. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol 2000;59: 495-503
43. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 1995;60:168-73
44. Choudhury GG, Grandaliano G, Jin D, Katz MS, Abboud HE. Activation of PLC and PI 3 kinase by PDGF receptor α is not sufficient for mitogenesis and migration in mesangial cells. Kidney Intl 2000;57:908-17
45. Yu J, Moon A, Choi Kim H. Both platelet-derived growth factor receptor (PDGFR)-α and PDGFR-β promotes murine fibroblast cell migration. Biochem Biophys Res Comm 2001;282:697-700
46. Lokker NA, Sullivan CM, Hollenbach SJ, Israel A, Giese NA. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: Evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 2002;62:3729-35
47. MAPK is independent of PDGF β-receptor tyrosine phosphorylation. Am J Physiol Lung Cell Mol Physiol 2001;281:L786-L798
48. Molander C, Kallin A, Izumi H, Ronnstrand L, Funa K. TNF-α suppresses the PDGF β-receptor kinase. Exp Cell Res 2000;258: 65-71
49. Taylor LM, Khachigian LM. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-β involves transactivation by Smads. J Biol Chem 2000;275:16709-16
50. Ras and Rho family GTPases. Exp Cell Res 2002;275:17-30
51. Oster SK, Marhin WW, Asker C, Facchini LM, Sedivy JM, Penn LZ. Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol Cell Biol 2000;20: 6768-78
52. Hiroto I, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K. Mechanism for the transcriptional repression by c-Myc on PDGF β-receptor. J Cell Sci 2001;114:1533-44
53. 2-terminal kinase-1 and antagonizes PDGF receptor-β-induced phenotypic transformation. J Biol Chem 2000;275:19076-82
54. Shimamura T, Hsu T, Colburn NH, Bejcek BE. Activation of NF-κB is required for PDGF-B chain to transform NIH3T3 cells. Exp Cell Res 2002;274:157-67
55. Choudhury GG. Akt serine threonine kinase regulates platelet-derived growth factor-induced dna synthesis in glomerular mesangial cells. J Biol Chem 2001;276:35636-43
56. Mundhenke C, Meyer K, Drew S, Friedl A. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 2002;160:185-94
57. Allen BL, Filla MS, Rapraeger AC. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol 2001;155:845-57
58. Zhang Z, Coomans C, David G. Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling. J Biol Chem 2001;276: 41921-29
59. Stachowiak EK, Fang X, Myers J, Dunham S, Stachowiak MK. cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J Neurochem 2003;84:1296-312